Skip to main content
Erschienen in: Familial Cancer 4/2010

01.12.2010

FAP, gastric cancer, and genetic counseling featuring children and young adults: a family study and review

verfasst von: Henry T. Lynch, Carrie Snyder, Janine M. Davies, Stephen Lanspa, Jane Lynch, Zoran Gatalica, Victoria Graeve, Jason Foster

Erschienen in: Familial Cancer | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Familial adenomatous polyposis is a highly complex and multifaceted colorectal cancer prone disorder which is often significantly confounded by extracolonic cancers inclusive of gastric cancer, a significant problem in the Orient. Gastric cancer in familial adenomatous polyposis is heavily influenced by fundic gland polyps which are often so voluminous as to defy effective endoscopic surveillance. This study involves more than two decades of investigation of an attenuated familial adenomatous polyposis family where gastric cancer posed an early diagnostic problem because it was obscured by multiple fundic gland polyps. Fundic gland polyps are common in familial adenomatous polyposis and attenuated familial adenomatous polyposis and, if voluminous, may interfere with effective endoscopic gastric cancer surveillance. This family is believed to be the first of its type reported with focus upon education and genetic counseling in the setting of a family information service. Cancer control in familial adenomatous polyposis may be partially resolved through use of familial colorectal cancer registries, with greater attention to family history and its interpretation, genetic counseling, and clinical translation for diagnosis and management.
Literatur
1.
Zurück zum Zitat Park JG, Park KJ, Ahn YO et al (1992) Risk of gastric cancer among Korean familial adenomatous polyposis patients. Report of three cases. Dis Colon Rectum 35:996–998CrossRefPubMed Park JG, Park KJ, Ahn YO et al (1992) Risk of gastric cancer among Korean familial adenomatous polyposis patients. Report of three cases. Dis Colon Rectum 35:996–998CrossRefPubMed
2.
Zurück zum Zitat Garrean S, Hering J, Saied A, Jani J, Espat NJ (2008) Gastric adenocarcinoma arising from fundic gland polyps in a patient with familial adenomatous polyposis syndrome. Am Surg 74:79–83PubMed Garrean S, Hering J, Saied A, Jani J, Espat NJ (2008) Gastric adenocarcinoma arising from fundic gland polyps in a patient with familial adenomatous polyposis syndrome. Am Surg 74:79–83PubMed
3.
Zurück zum Zitat Lynch HT, de la Chapelle A (1999) Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 36:801–818PubMed Lynch HT, de la Chapelle A (1999) Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 36:801–818PubMed
4.
Zurück zum Zitat Groves C, Lamlum H, Crabtree M et al (2002) Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis. Am J Pathol 160:2055–2061PubMed Groves C, Lamlum H, Crabtree M et al (2002) Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis. Am J Pathol 160:2055–2061PubMed
5.
Zurück zum Zitat Lynch HT, Smyrk T, Lanspa SJ et al (1988) Flat adenomas in a colon cancer-prone kindred. J Natl Cancer Inst 80:278–282CrossRefPubMed Lynch HT, Smyrk T, Lanspa SJ et al (1988) Flat adenomas in a colon cancer-prone kindred. J Natl Cancer Inst 80:278–282CrossRefPubMed
6.
Zurück zum Zitat Lynch HT, Smyrk TC, Watson P et al (1992) Hereditary flat adenoma syndrome: a variant of familial adenomatous polyposis? Dis Colon Rectum 35:411–421CrossRefPubMed Lynch HT, Smyrk TC, Watson P et al (1992) Hereditary flat adenoma syndrome: a variant of familial adenomatous polyposis? Dis Colon Rectum 35:411–421CrossRefPubMed
7.
Zurück zum Zitat Lynch HT, Smyrk TC, Lanspa SJ et al (1993) Upper gastrointestinal manifestations in families with hereditary flat adenoma syndrome. Cancer 71:2709–2714CrossRefPubMed Lynch HT, Smyrk TC, Lanspa SJ et al (1993) Upper gastrointestinal manifestations in families with hereditary flat adenoma syndrome. Cancer 71:2709–2714CrossRefPubMed
8.
Zurück zum Zitat Attard TM, Tajouri T, Peterson KD, Tinley S, Thorson AG, Lynch HT (2008) Familial adenomatous polyposis in children younger than age 10 years: A multidisciplinary clinic experience. Dis Colon Rectum 51:207–212CrossRefPubMed Attard TM, Tajouri T, Peterson KD, Tinley S, Thorson AG, Lynch HT (2008) Familial adenomatous polyposis in children younger than age 10 years: A multidisciplinary clinic experience. Dis Colon Rectum 51:207–212CrossRefPubMed
9.
10.
Zurück zum Zitat Lynch HT, Smyrk T, McGinn T et al (1995) Attenuated familial adenomatous polyposis (AFAP): a phenotypically and genotypically distinctive variant of FAP. Cancer 76:2427–2433CrossRefPubMed Lynch HT, Smyrk T, McGinn T et al (1995) Attenuated familial adenomatous polyposis (AFAP): a phenotypically and genotypically distinctive variant of FAP. Cancer 76:2427–2433CrossRefPubMed
11.
Zurück zum Zitat Arvanitis ML, Jagelman DG, Fazio VN, Lavery IC, McGannon E (1990) Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 33:639–642CrossRefPubMed Arvanitis ML, Jagelman DG, Fazio VN, Lavery IC, McGannon E (1990) Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 33:639–642CrossRefPubMed
12.
Zurück zum Zitat Belchetz LA, Bert T, Bapat BV, Cohen Z, Gallinger S (1996) Changing causes of mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 39:384–387CrossRefPubMed Belchetz LA, Bert T, Bapat BV, Cohen Z, Gallinger S (1996) Changing causes of mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 39:384–387CrossRefPubMed
13.
Zurück zum Zitat Bulow S (2003) Results of national registration of familial adenomatous polyposis. Gut 52:742–746CrossRefPubMed Bulow S (2003) Results of national registration of familial adenomatous polyposis. Gut 52:742–746CrossRefPubMed
14.
Zurück zum Zitat Lynch HT, Fitzgibbons R Jr (1996) Surgery, desmoid tumors and familial adenomatous polyposis: case report and literature review. Am J Gastroenterol 91:2598–2601PubMed Lynch HT, Fitzgibbons R Jr (1996) Surgery, desmoid tumors and familial adenomatous polyposis: case report and literature review. Am J Gastroenterol 91:2598–2601PubMed
15.
Zurück zum Zitat Lynch HT, Fitzgibbons R Jr, Chong S et al (1994) Use of doxorubicin and dacarbazine for the management of unresectable intra-abdominal desmoid tumors in Gardner’s syndrome. Dis Colon Rectum 37:260–267CrossRefPubMed Lynch HT, Fitzgibbons R Jr, Chong S et al (1994) Use of doxorubicin and dacarbazine for the management of unresectable intra-abdominal desmoid tumors in Gardner’s syndrome. Dis Colon Rectum 37:260–267CrossRefPubMed
16.
Zurück zum Zitat de Silva DC, Wright MF, Stevenson DAJ et al (1996) Cranial desmoid tumor associated with homozygous inactivation of the adenomatous polyposis coli gene in a 2-year-old girl with familial adenomatous polyposis. Cancer 77:972–976CrossRefPubMed de Silva DC, Wright MF, Stevenson DAJ et al (1996) Cranial desmoid tumor associated with homozygous inactivation of the adenomatous polyposis coli gene in a 2-year-old girl with familial adenomatous polyposis. Cancer 77:972–976CrossRefPubMed
17.
Zurück zum Zitat Jarvinen HJ (1987) Desmoid disease as a part of familial adenomatous polyposis coli. Acta Chir Scand 153:379–383PubMed Jarvinen HJ (1987) Desmoid disease as a part of familial adenomatous polyposis coli. Acta Chir Scand 153:379–383PubMed
18.
Zurück zum Zitat Kratzer G, Kasumi A, Krush AJ (1991) Gardner syndrome: study and follow up of a family. Am J Med Genet 41:393–397CrossRefPubMed Kratzer G, Kasumi A, Krush AJ (1991) Gardner syndrome: study and follow up of a family. Am J Med Genet 41:393–397CrossRefPubMed
19.
Zurück zum Zitat Yazici N, Yalçin B, Söylemezoglu F et al (2008) Intracranial desmoid tumor with familial adenomatous polyposis coli. Pediatr Neurosurg 44:140–143CrossRefPubMed Yazici N, Yalçin B, Söylemezoglu F et al (2008) Intracranial desmoid tumor with familial adenomatous polyposis coli. Pediatr Neurosurg 44:140–143CrossRefPubMed
20.
Zurück zum Zitat Church J, Lynch C, Neary P, LaGuardia L, Elayi E (2008) A desmoid tumor-staging system separates patients with intra-abdominal, familial adenomatous polyposis-associated desmoid disease by behavior and prognosis. Dis Colon Rectum 51:897–901CrossRefPubMed Church J, Lynch C, Neary P, LaGuardia L, Elayi E (2008) A desmoid tumor-staging system separates patients with intra-abdominal, familial adenomatous polyposis-associated desmoid disease by behavior and prognosis. Dis Colon Rectum 51:897–901CrossRefPubMed
21.
Zurück zum Zitat Brasseur B, Dahan K, Beauloye V et al (2009) Multiple neoplasia in a 15-year-old girl with familial adenomatous polyposis. J Pediatr Hematol Oncol 31:530–532CrossRefPubMed Brasseur B, Dahan K, Beauloye V et al (2009) Multiple neoplasia in a 15-year-old girl with familial adenomatous polyposis. J Pediatr Hematol Oncol 31:530–532CrossRefPubMed
22.
Zurück zum Zitat Gallagher MC, Phillips RKS, Bulow S (2006) Surveillance and management of upper gastrointestinal disease in Familial Adenomatous Polyposis. Fam Cancer 5:263–273CrossRefPubMed Gallagher MC, Phillips RKS, Bulow S (2006) Surveillance and management of upper gastrointestinal disease in Familial Adenomatous Polyposis. Fam Cancer 5:263–273CrossRefPubMed
23.
Zurück zum Zitat Groves CJ, Saunders BP, Spigelman AD, Phillips RKS (2002) Duodenal cancer in patients with familial adenomatous polyposis (FAP): Results of a 10 year prospective study. Gut 50:636–641CrossRefPubMed Groves CJ, Saunders BP, Spigelman AD, Phillips RKS (2002) Duodenal cancer in patients with familial adenomatous polyposis (FAP): Results of a 10 year prospective study. Gut 50:636–641CrossRefPubMed
24.
Zurück zum Zitat Offerhaus GJ, Giardiello FM, Krush AJ et al (1992) The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 102:1980–1982PubMed Offerhaus GJ, Giardiello FM, Krush AJ et al (1992) The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 102:1980–1982PubMed
25.
Zurück zum Zitat Abraham SC, Nobukawa B, Giardiello FM, Hamilton SR, Wu TT (2000) Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am J Pathol 157:747–754PubMed Abraham SC, Nobukawa B, Giardiello FM, Hamilton SR, Wu TT (2000) Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am J Pathol 157:747–754PubMed
26.
Zurück zum Zitat Bianchi LK, Burke CA, Bennett AE, Lopez R, Hasson H, Church JM (2008) Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol 6:180–185CrossRefPubMed Bianchi LK, Burke CA, Bennett AE, Lopez R, Hasson H, Church JM (2008) Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol 6:180–185CrossRefPubMed
27.
Zurück zum Zitat Dunn KB, Chey WY, Gibbs JF (2008) Total gastrectomy for gastric dysplasia in a patient with attenuated familial adenomatous polyposis syndrome. J Clin Oncol 26:3641–3642CrossRef Dunn KB, Chey WY, Gibbs JF (2008) Total gastrectomy for gastric dysplasia in a patient with attenuated familial adenomatous polyposis syndrome. J Clin Oncol 26:3641–3642CrossRef
28.
Zurück zum Zitat Spirio L, Otterud B, Stauffer D et al (1992) Linkage of a variant or attenuated form of adenomatous polyposis coli to the adenomatous polyposis coli (APC) locus. Am J Hum Genet 51:92–100PubMed Spirio L, Otterud B, Stauffer D et al (1992) Linkage of a variant or attenuated form of adenomatous polyposis coli to the adenomatous polyposis coli (APC) locus. Am J Hum Genet 51:92–100PubMed
29.
Zurück zum Zitat Burt RW, Leppert MF, Slattery ML et al (2004) Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology 127:444–451CrossRefPubMed Burt RW, Leppert MF, Slattery ML et al (2004) Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology 127:444–451CrossRefPubMed
30.
Zurück zum Zitat Attard TM, Giardiello FM, Argani P, Cuffari C (2001) Fundic gland polyposis with high-grade dysplasia in a child with attenuated familial adenomatous polyposis and familial gastric cancer. J Pediatr Gastroenterol Nutr 32:215–218CrossRefPubMed Attard TM, Giardiello FM, Argani P, Cuffari C (2001) Fundic gland polyposis with high-grade dysplasia in a child with attenuated familial adenomatous polyposis and familial gastric cancer. J Pediatr Gastroenterol Nutr 32:215–218CrossRefPubMed
31.
Zurück zum Zitat Soravia C, Berk T, Madlensky L et al (1998) Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet 62:1290–1301CrossRefPubMed Soravia C, Berk T, Madlensky L et al (1998) Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet 62:1290–1301CrossRefPubMed
32.
Zurück zum Zitat Friedl W, Meuschel S, Caspari R et al (1996) Attenuated familial adenomatous polyposis due to a mutation in the 3′ part of the APC gene. A clue for understanding the function of the APC protein. Hum Genet 97:579–584CrossRefPubMed Friedl W, Meuschel S, Caspari R et al (1996) Attenuated familial adenomatous polyposis due to a mutation in the 3′ part of the APC gene. A clue for understanding the function of the APC protein. Hum Genet 97:579–584CrossRefPubMed
33.
Zurück zum Zitat Zwick A, Munir M, Ryan CK et al (1997) Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli. Gastroenterology 113:659–663CrossRefPubMed Zwick A, Munir M, Ryan CK et al (1997) Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli. Gastroenterology 113:659–663CrossRefPubMed
34.
Zurück zum Zitat Hofgartner W, Thorp M, Ramus M et al (1999) Gastric adenocarcinoma associated with fundic gland polyps in a patient with attenuated familial adenomatous polyposis. Am J Gastroenterol 94:2275–2281PubMed Hofgartner W, Thorp M, Ramus M et al (1999) Gastric adenocarcinoma associated with fundic gland polyps in a patient with attenuated familial adenomatous polyposis. Am J Gastroenterol 94:2275–2281PubMed
35.
Zurück zum Zitat Koopman HM, Baars RM, Chaplin J, Zwinderman KH (2004) Illness through the eyes of the child: the development of children’s understanding of the causes of illness. Patient Educ Couns 55:363–370CrossRefPubMed Koopman HM, Baars RM, Chaplin J, Zwinderman KH (2004) Illness through the eyes of the child: the development of children’s understanding of the causes of illness. Patient Educ Couns 55:363–370CrossRefPubMed
36.
Zurück zum Zitat Eiser C (1985) Changes in understanding of illness as the child grows. Arch Dis Child 60:489–492CrossRefPubMed Eiser C (1985) Changes in understanding of illness as the child grows. Arch Dis Child 60:489–492CrossRefPubMed
Metadaten
Titel
FAP, gastric cancer, and genetic counseling featuring children and young adults: a family study and review
verfasst von
Henry T. Lynch
Carrie Snyder
Janine M. Davies
Stephen Lanspa
Jane Lynch
Zoran Gatalica
Victoria Graeve
Jason Foster
Publikationsdatum
01.12.2010
Verlag
Springer Netherlands
Erschienen in
Familial Cancer / Ausgabe 4/2010
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-010-9352-7

Weitere Artikel der Ausgabe 4/2010

Familial Cancer 4/2010 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.